Chamber and committees

The Scottish Government publishes an update on progress on all major capital investment projects every 6 months in its Infrastructure Investment Plan and includes information on the following the projects:

• NHS Grampian - Aberdeen Baird Family Hospital and ANCHOR Centre
• National Waiting Times Centre Board - Hospital Expansion Programme - Phase 2
• NHS Lothian - National Treatment Centre
• NHS Highland – National Treatment Centre
• NHS Forth Valley - National Treatment Centre
• NHS Greater Glasgow and Clyde - North East Hub
• NHS Ayrshire & Arran - Foxgrove (National Secure Adolescent Inpatient Service)
• NHS Tayside - Ninewells Electrical Infrastructure Zone 3
• NHS Ayrshire & Arran - National Treatment Centre - Ayrshire & Arran

The full report is published here:

Infrastructure Investment Plan 2021-22 to 2025-26: Major capital projects progress update (September 2022) - gov.scot (www.gov.scot)

The Scottish Government has received no reports of shortages or problems with production of radionuclide leading to delays in scans for prostate patients.

The Scottish Government remains committed to delivering Anne’s Law which will support the rights of people living in adult care homes to connect with their loved ones.

At Stage 1 of the National Care Service (Scotland) Bill, evidence was heard from seven committees and many individuals and representatives on a wide range of topics. An extension will allow the Scottish Parliament and the Scottish Government the necessary time to consider all of the evidence to best inform the development of Anne’s Law and the Bill.

Meantime, the Scottish Government has already utilised existing powers to adopt the core foundations of Anne’s Law through the development of two new Heath and Social Care Standards introduced in April 2022.

The new Standards established that people living in care homes should have the right to see someone who is important to them, even during an outbreak and be able to name a person or persons who can directly participate in meeting their care needs. The Care Inspectorate now refer to these Standards when registering, inspecting and supporting care homes.

In addition Public Health Scotland COVID guidance now reflects that three named visitors can visit a resident, one per day, in the event of an outbreak, and essential visiting for end-of-life care and distress should always be supported, regardless of the circumstances.

The strengthened Public Health guidance and the new Standards have helped to minimise disruption to visiting, with 99% of adult care homes reporting that they are supporting indoor visiting.

During the extension to Stage 1 of the National Care Service (Scotland) Bill the Scottish Government will continue to work with care home providers, relatives and organisations to develop the detail of Anne’s Law and prepare for its implementation.

The mean and median gender pay gaps in Core Scottish Government is detailed in the following table:

Professor Anna Glasier OBE was appointed as the first Women’s Health Champion for Scotland on 26 January 2023.

Professor Glasier has been contracted to work four days a month, with her tenure coming to an end in June 2024.

Professor Glasier recently published her first Women’s Health Champion update blog which can be found here: Health and Social Care My first update as Women's Health Champion - Health and Social Care (blogs.gov.scot)

The Scottish Government provides an annual allocation to Health Boards to meet the costs of providing general medical services either through contracting with GP practices or directly by Health Boards. NHS Grampian will continue to receive an appropriate level of funding based on the practice’s registered patients.

Aberdeenshire Health & Social Care Partnership and NHS Grampian are keeping my officials abreast of developments.

The Women’s Health Plan includes a medium-term action to “ensure women are properly supported around the time of menopause to assess their future risk of osteoporosis and fractures and given appropriate lifestyle advice” and action is being taken to progress this work.

On 5 th April, Professor Anna Glasier, the Women’s Health Champion, met with the Royal Osteoporosis Society to discuss the higher risk of osteoporosis for women and the impact that this has on their health outcomes in later life.

In addition, accessible information has been made available to women via the menopause resource on the NHS Inform Women’s Health Platform. The resource highlights that women who have been through menopause are at an increased risk of developing osteoporosis as a result of the lower level of oestrogen in the body and provides advice on what women can do to reduce their chances of developing osteoporosis. Information is included on lifestyle changes like exercise and nutrition to improve bone health as well as advice on Hormone Replacement Therapy (HRT).

The Scottish Government has also commissioned NHS Education for Scotland (NES) to create a bespoke training package and framework focussed on menopause and menstrual health for GPs and others working in Primary Care. This package will take a life course approach, including ensuring healthcare professionals are able to support women in being aware of the risk of osteoporosis around the time of menopause – and what can help.

We are jointly funding a £250,000 endometriosis research project with the charity Wellbeing of Women. The research project, which will primarily be run by researchers at The University of Edinburgh, will look at the drug dichloroacetate in the management of endometriosis-associated pain.

Additionally, in January 2023 our Chief Scientist Office announced funding for the ENDOCAN project, led by researchers at The University of Edinburgh. Through a large scale UK-wide trial, the research will investigate whether a cannabinoid can reduce endometriosis-associated pain. Funding of £299,509 has been committed to this 30 month project.

The Chief Scientist Office is also currently inviting applications for Applied Health Research Programmes . An applied health research programme is envisaged to comprise a coherent group of inter-related projects that together can have a high level of direct impact to address an important Scottish population health or NHS challenge within the lifetime of the programme or soon thereafter.

We recognise the challenges facing remote and rural NHS Boards in balancing paramount safety considerations with the delivery of care as close to home as practicable. Work is ongoing to ensure that services are developed in a flexible way, recognising local population needs and geographic challenges. We expect NHS Boards to engage constructively with local communities in this and understand that there is significant community engagement work already underway across remote and rural NHS Board areas.

Figures for median travel distance for obstetric and/ or gynaecology services are not collected centrally. The requested Information on how many obstetrics and gynaecology consultants have been recruited across all NHS Boards in each of the past 5 years can be found on the TURAS NHS Education for Scotland workforce statistics site at: NHS Scotland workforce | Turas Data Intelligence . NHS Boards are responsible for planning and delivering local services, including maternity services. This includes planning where those services should be located, based on local population need and any geographic challenges, and staff recruitment.

The Scottish Government remains fully committed to achieving the elimination of Hepatitis C in Scotland by the end of the 2024/25 financial year.

Scotland already has a renowned approach for tackling Hepatitis C, with NHS Tayside eliminating it within the health board area, 11 years ahead of the World Health Organisation (WHO) target.

The last Public Health Scotland report (2022) demonstrated the major progress that has been made so far; for example, the prevalence of a chronic Hepatitis C infection amongst people who inject drugs has almost halved between 2015 and 2020 and there has been as much as a 70% reduction in some parts of Scotland. In addition 80% of individuals with a chronic hepatitis C infection have also been initiated onto treatment, exceeding the World Health Organisations treatment target.

However, we know that to achieve elimination and meet our target will take a concerted effort on a national scale. We will continue to proactively collaborate with the Hepatitis C Elimination Implementation Strategy Group to ascertain where our support is most required as we work towards our goal of elimination.